Trial
NCT06419985
Ketamine HCl Prolonged Release Oral Tablets for CRPS
Phase IISUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
University of Southern California
Collaborators
—
Condition
Complex Regional Pain Syndromes
Intervention
80mg/day Ketamine HCl Prolonged Release
Why stopped
Difficulty clearing through the FDA
Provenance
Dataset: 2026-07-31 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-27